Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy



Status:Recruiting
Conditions:Other Indications, Neurology, Gastrointestinal, Epilepsy
Therapuetic Areas:Gastroenterology, Neurology, Other
Healthy:No
Age Range:18 - 70
Updated:8/11/2018
Start Date:August 10, 2015
End Date:August 10, 2020
Contact:Sukumar Deeptha, PhD
Email:deeptha.sukumar@drexel.edu
Phone:267 359 5854

Use our guide to learn which trials are right for you!

The objective of this study is to determine the role of magnesium on bone and vitamin D
metabolism in patients receiving anti-epileptic medications.


Inclusion Criteria:

- Individuals receiving anti-epileptic drugs as a treatment for epilepsy

Exclusion Criteria:

- Individuals who are pregnant or breastfeeding, receiving cancer treatments, have liver
or kidney diseases, autoimmune diseases, or other diseases that may interfere with
vitamin D and magnesium metabolism.
We found this trial at
2
sites
1601 Cherry Street
Philadelphia, Pennsylvania 19102
Phone: 267-359-5854
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
3301 Lancaster Avenue
Philadelphia, Pennsylvania 19102
Phone: 215-553-7018
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials